VWAP

Dundee Precious Metals Announces Acquisition of Osino

Retrieved on: 
月曜日, 12月 18, 2023
TSX Venture Exchange, Resource, Government, PIN, CapeNature, Committee, Arrangement, DPM, Consideration, Multilateral, ESG, Twin, Capital, Tax, Private, Hand, Mining, BMO Capital Markets, Transaction, Engineering, Webcast, Toronto Stock Exchange, VWAP, LLP, Acquisition, Gold, OSI, Rakita, TSX, Minority, Security (finance)

Upon completion of the Transaction, DPM will issue 13,766,364 shares to Osino shareholders and existing Osino shareholders will own approximately 7% of the combined company.

Key Points: 
  • Upon completion of the Transaction, DPM will issue 13,766,364 shares to Osino shareholders and existing Osino shareholders will own approximately 7% of the combined company.
  • David Rae, President and Chief Executive Officer of Dundee Precious Metals, made the following comments in relation to the Osino acquisition:
    “Twin Hills represents a unique opportunity to add a high-quality development asset in an excellent mining jurisdiction to our portfolio.
  • The Board of Directors of Osino (the “Osino Board”) appointed a special committee of independent directors (the “Special Committee”) to consider and make a recommendation to the Osino Board with respect to the Transaction.
  • Accordingly, the Osino Board and the Special Committee recommend that Osino shareholders vote in favour of the Transaction.

Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMO

Retrieved on: 
月曜日, 12月 4, 2023
Depreciation, Sale, Virus, Acquisition, Completion, European, Transaction, CDMO, Official List, Potyvirus, VWAP, OXB, London Stock Exchange

Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMO

Key Points: 
  • Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMO
    Provides Oxford Biomedica with multi viral vector CDMO capabilities – to be made available across the Company’s six manufacturing sites in EU, US and UK
    Oxford, UK – 4 December 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led cell and gene therapy CDMO, today announces that it has entered into a sale and purchase agreement (the “Agreement”) with TSGH SAS, a subsidiary of Institut Mérieux SA ("Institut Mérieux"), for the acquisition of ABL Europe SAS (“ABL Europe”) (the "Transaction").
  • The acquisition of ABL Europe will consolidate Oxford Biomedica's operations into a global pure-play CDMO in the cell and gene therapy space.
  • ABL Europe currently works on more than 10 cell and gene therapy programmes spanning disease areas including more than six different vector types.
  • Dr. Frank Mathias, Chief Executive Officer of Oxford Biomedica, commented: “The acquisition of ABL Europe strengthens Oxford Biomedica's operations into a global pure-play CDMO in the cell and gene therapy space.

Brunswick Exploration Exercises Complete Globex Option

Retrieved on: 
火曜日, 11月 28, 2023
Lithium, Mirage, BRW, Exercise, GMX, Geo, TSX, Cell, Toronto Stock Exchange, VWAP, Security (finance)

Under the option agreement, Brunswick was required to make payments totaling $500,000, (half in cash and half in shares) and undertake a minimum of $1,000,000 in exploration work over four years.

Key Points: 
  • Under the option agreement, Brunswick was required to make payments totaling $500,000, (half in cash and half in shares) and undertake a minimum of $1,000,000 in exploration work over four years.
  • Brunswick have notified Globex that they have met the minimum $1,000,000 exploration expenditures and Globex has received an additional $212,500 in cash and 216,395 Brunswick shares, representing a cash equivalent of $212,500 (216,395 shares at 30-day VWAP average of $0.982/share).
  • The full exercise of the option has occurred approximately 11 months after signature of the 4-year option agreement.
  • Globex expects that Brunswick has exercised the entire option agreement so much ahead of time for good reason.

Fusion Fuel Green Announces Strategic Tranched Financing from Belike Nominees Pty Ltd., a Macquarie Group Company

Retrieved on: 
月曜日, 11月 27, 2023
Sales management, Volume, Funding, Sale, Convertible, Note, VWAP, Security (finance)

Although subject to change, based on current market conditions, the initial tranche is not expected to be greater than 10% of the total Financing.

Key Points: 
  • Although subject to change, based on current market conditions, the initial tranche is not expected to be greater than 10% of the total Financing.
  • Until the conditions precedent as described herein are satisfied or waived, there can be no assurance that any portion of the Financing will be consummated.
  • Frederico Figueira de Chaves, CEO of Fusion Fuel, stated, “We are excited to enter into this agreement with Macquarie.
  • There can be no assurance that the Company will be able to complete the private placement on the terms described herein or at all.

ORYZON Announces a New Financing Through a Convertible Bond Program For a Total Amount of Up To €45 Million

Retrieved on: 
火曜日, 11月 21, 2023
Note, Borderline personality disorder, Genomics, VWAP, Pharmaceutical industry

The financing program consists of several tranches of up to €5 million each to be drawn at the discretion of Oryzon, subject to customary conditions and to the progress of the ongoing clinical trials and the liquidity of the Oryzon share.

Key Points: 
  • The financing program consists of several tranches of up to €5 million each to be drawn at the discretion of Oryzon, subject to customary conditions and to the progress of the ongoing clinical trials and the liquidity of the Oryzon share.
  • The Convertible Notes (CN) have a maturity of 48 months, zero interest rate, and have no warrants associated.
  • Oryzon has the right to execute the redemption of any or all Notes at a premium of 3%.
  • As a responsible and loyal financial partner, Nice & Green will remain attentive to the evolving financing needs of Oryzon in the near and long term.”

Diana Shipping Inc. Announces Pro-Rata Distribution of Warrants to Purchase Common Stock

Retrieved on: 
月曜日, 11月 20, 2023
Sale, Date, Holder, Risk, Warrant, DSX, VWAP, Security (finance), Exercise

Holders may exercise their Warrants for shares of common stock as will be specified under the terms in the warrant agreement.

Key Points: 
  • Holders may exercise their Warrants for shares of common stock as will be specified under the terms in the warrant agreement.
  • The Warrants will be distributed pro-rata to Holders of the Company’s common stock.
  • Each Warrant will entitle the Holder to purchase, at the Holder’s sole and exclusive election, at the exercise price, one share of common stock plus, to the extent described below, the Bonus Share Fraction.
  • The Company will file a prospectus supplement, under its existing shelf registration statement, registering the shares of common stock underlying the Warrants.

Canadian Banc Corp. Monthly Dividend Declaration for Class A & Preferred Share

Retrieved on: 
月曜日, 11月 20, 2023
Policy, Bank, Royal Bank of Canada, Commerce, The Company, Toronto-Dominion Bank, Scotiabank, Bank of Montreal, National bank, VWAP, National Bank of Canada

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Canadian Banc Corp. (The "Company") declares its monthly distribution of $0.11988 for each Class A share and $0.06667 for each Preferred share.

Key Points: 
  • TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Canadian Banc Corp. (The "Company") declares its monthly distribution of $0.11988 for each Class A share and $0.06667 for each Preferred share.
  • Distributions are payable December 8, 2023 to shareholders on record as at November 30, 2023.
  • As a result, Class A shareholders of record on November 30, 2023 will receive a dividend of $0.11988 per share based on the VWAP of $9.59 payable on December 8, 2023.
  • Since inception Class A shareholders have received a total of $21.32 per share and Preferred shareholders have received a total of $10.04 per share inclusive of this distribution, for a combined total of $31.35.

Dividend Select 15 Corp. Declares Monthly Dividend

Retrieved on: 
月曜日, 11月 20, 2023
Policy, The Company, VWAP, Holding company

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dividend Select 15 Corp. (The "Company") declares its monthly distribution of $0.04733 per Equity share.

Key Points: 
  • TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dividend Select 15 Corp. (The "Company") declares its monthly distribution of $0.04733 per Equity share.
  • The distribution is payable December 8, 2023 to shareholders on record as of November 30, 2023.
  • As a result, Equity shareholders of record on November 30, 2023 will receive a dividend of $0.04733 per share based on the VWAP of $5.68 payable on December 8, 2023.
  • The Company invests in a portfolio of 15 Canadian companies selected from the following 20 company universe which are among the highest Canadian dividend yielding stocks.

Income Financial Declares Monthly Distribution

Retrieved on: 
月曜日, 11月 20, 2023
Policy, VWAP, Cryptocurrency

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Income Financial Trust ("Income Financial") declares its monthly distribution of $0.05250 per unit.

Key Points: 
  • TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Income Financial Trust ("Income Financial") declares its monthly distribution of $0.05250 per unit.
  • Under the distribution policy announced on November 18, 2013, the monthly distribution is determined by applying a 10.00% annualized rate on the volume weighted average market price (VWAP) of Income Financial's units over the last 3 trading days of the preceding month.
  • Income Financial unitholders have received a total of $37.97 per unit in distributions since inception, inclusive of this distribution.
  • Income Financial invests in a portfolio of North American financial services companies including some of the strongest Canadian & U.S. banks, life insurance and investment firms.

$4.3 million Placement

Retrieved on: 
月曜日, 11月 20, 2023
FIRB, Placement, Documentation, ASX, Acquisition, XAM, News, Ord Minnett, TSX, VWAP, Horizon Forbidden West, Security (finance)

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce the Company has received commitments for a placement to eligible professional and sophisticated investors of 78,181,818 fully-paid ordinary shares in Xanadu (New Shares) at an issue price of $0.055 each to raise A$4,299,999.99 (before costs) (Placement). The Placement will complete in two tranches. The first tranche, being the issue of 62,996,490 New Shares, is unconditional and will be issued pursuant to the Company’s existing placement capacity under ASX Listing Rule 7.1 (First Tranche). The second tranche, being the proposed subscription of 15,185,328 New Shares by Xanadu’s major shareholder Zijin Mining Group Co., Ltd (Zijin),1 is subject to formal documentation and a number of conditions set out below (Second Tranche).

Key Points: 
  • The first tranche, being the issue of 62,996,490 New Shares, is unconditional and will be issued pursuant to the Company’s existing placement capacity under ASX Listing Rule 7.1 (First Tranche).
  • Includes participation by Zijin on a proportionate basis (A$0.8 million), subject to Australia Foreign Investment Review Board (FIRB) and Xanadu shareholder approval.
  • Placement of the Second Tranche New Shares will occur 10 business days after the last of the Zijin Conditions are satisfied.
  • We will notify the market shortly of a date for our Extraordinary Meeting to approve Zijin’s share of this placement.